B.S., Emory University, 1978; M.D., SUNY Downstate Medical Center, 1982; Fellowship in Endocrinology, University of Massachusetts Worcester, 1988
Area(s) of Specialization:
Diabetes, Insulin Resistance, Healthcare Delivery
My interests have focused on approaches to minimizing consequences of diabetes and related cardiovascular complications through lifestyle modification and improved delivery of community health services. Major areas of research have focused on:
- Working with medical home teams and minority communities to develop meaningful approaches to lifestyle modification in the clinic and in the neighborhood to positively affect consequences of chronic diseases;
- Evaluating the impact of mild physical activity on glucose concentrations and insulin sensitivity in sedentary individuals;
- Defining the relationship between walking activity and exercise intensity;
- Examining combinations of medications with physical activity on insulin sensitivity and cardiovascular risk.
Other interdisciplinary collaborations have included: determining the impact of factors such as medications, inflammation or exercise on skeletal muscle structure and cellular signaling.
Current efforts emphasize the need for developing a well-trained public health workforce. One group of great interest is “front-line” health care workers who have the potential to greatly improve the delivery of care to people at risk for or those living with diabetes. Their importance in monitoring and reinforcing healthcare messages and strategies, through systems such as the patient centered medical home, is a new area of investigation.
Lazar HL, McDonnell MM, Chipkin S, Fitzgerald C, Bliss C, Cabral H. Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Ann Surg, 254:458-64. doi: 10.1097/SLA.0b013e31822c5d78.
Malin SK, Gerber R, Chipkin SR, Braun B. Independent and combined effects of exercise training and metformin on insulin sensitivity in individuals with prediabetes. Diabetes Care, 35:131-6. doi:10.2337/dc11-0925.
Taylor BA, Panza G, Pescatello LS, Chipkin S, Gipe D, Shao W, White CM, Thompson PD. Serum PCSK9 Levels Distinguish Individuals Who Do Not Respond to High-Dose Statin Therapy with the Expected Reduction in LDL-C. J Lipids. doi: 10.1155/2014/140723.
Rataj S, Weber L, DiFulvio G, Heffernan D, Gerber D, Chipkin SR. Gaps Between Self-Rated Job Importance and Abilities for Community Health Workers in Massachusetts, Int Q Comm Health Ed. doi: 10.1177/0272684X16670207
Chipkin SR and Kim F. Ten Most Important Things to Know About Caring for Transgender Patients. Am J Med. https://doi.org/10.1016/j.amjmed.2017.06.019.